kynurenic acid has been researched along with Remission, Spontaneous in 1 studies
Kynurenic Acid: A broad-spectrum excitatory amino acid antagonist used as a research tool.
kynurenic acid : A quinolinemonocarboxylic acid that is quinoline-2-carboxylic acid substituted by a hydroxy group at C-4.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rejdak, K | 1 |
| Bartosik-Psujek, H | 1 |
| Dobosz, B | 1 |
| Kocki, T | 1 |
| Grieb, P | 1 |
| Giovannoni, G | 1 |
| Turski, WA | 1 |
| Stelmasiak, Z | 1 |
1 other study available for kynurenic acid and Remission, Spontaneous
| Article | Year |
|---|---|
Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients.
Topics: Adult; Female; Humans; Kynurenic Acid; Male; Multiple Sclerosis, Chronic Progressive; Multiple Scler | 2002 |